On December 23, 2014, a response to the motion/application for approval of a settlement pursuant to rule 9019 was filed in the bankruptcy case of New England Compounding Pharmacy, Inc. and its affiliates.
The filing was assigned docket number 1093 and is described on the court’s official docket as follows:
Response Joinder of the Official Committee of Unsecured Creditors to Chapter 11 Trustee’s Motion to Approve Settlement Agreement with the Ohio State Board of Pharmacy and Request to Limit Notice with certificate of service filed by Creditor Committee Official Committee of Unsecured Creditors Re:  Motion filed by Trustee Paul D. Moore to Approve Compromise Under Rule 9019 with certificate of service. (Baldiga, William)
New England Compounding Pharmacy, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 21, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Massachusetts. The case number for the lead bankruptcy case is 12-19882. The bankruptcy case is currently assigned to United States Bankruptcy Judge Henry Boroff. The law firm of Murtha Cullina LLP is acting as lead bankruptcy counsel to New England Compounding Pharmacy, Inc. in the bankruptcy case.